{
    "clinical_study": {
        "@rank": "153221", 
        "arm_group": [
            {
                "arm_group_label": "Oxygen", 
                "arm_group_type": "Active Comparator", 
                "description": "oxygen administration via a nasal cannula at a rate of 3 L/min during nights spent at 2048 m"
            }, 
            {
                "arm_group_label": "Sham oxygen", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Sham oxygen (room air) administration via a nasal cannula at a rate of 3 L/min during nights spent at 2048 m"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of nocturnal oxygen therapy during a\n      stay at moderate altitude on breathing and sleep of patients with chronic obstructive lung\n      disease."
        }, 
        "brief_title": "Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chronic Obstructive Pulmonary Disease (COPD)", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with moderate to severe chronic obstructive pulmonary disease living below 800 m\n      will be invited to participate in a randomized, cross-over field trial evaluating the\n      hypothesis that nocturnal breathing and sleep during nights spent at moderate altitude are\n      improved by oxygen therapy via a nasal cannula compared to room air (sham oxygen). Outcomes\n      will be assessed at low altitude (Zurich, 490 m, baseline), and during 2 study periods of 2\n      nights each spent at moderate altitude (St. Moritz Salastrains, 2048 m) separated by a\n      wash-out period of at least 2 weeks spent at low altitude (<800 m)."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  chronic obstructive pulmonary disease (COPD), GOLD grade 2-3\n\n          -  residents at low altitude (<800 m)\n\n        Exclusion Criteria:\n\n          -  unstable condition, COPD exacerbation\n\n          -  mild (GOLD 1) or very severe COPD (GOLD 4)\n\n          -  requirement for oxygen therapy at low altitude residence\n\n          -  hypoventilation\n\n          -  pulmonary hypertension\n\n          -  more than mild or unstable cardiovascular disease\n\n          -  use of drugs that affect respiratory center drive\n\n          -  internal, neurologic or psychiatric disease that interfere with protocol compliance\n             including current heavy smoking (>20 cigarettes per day), inability to perform 6 min\n             walk test.\n\n          -  previous intolerance to moderate altitude (<2600m).\n\n          -  exposure to altitudes >1500m for >2 days within the last 4 weeks before the study.\n\n          -  pregnant or nursing patients"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02150590", 
            "org_study_id": "2013-0088V2A3B"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Oxygen", 
                    "Sham oxygen"
                ], 
                "description": "Nocturnal nasal oxygen during stay at 2048 m", 
                "intervention_name": "Oxygen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Oxygen", 
                    "Sham oxygen"
                ], 
                "intervention_name": "sham oxygen (room air)", 
                "intervention_type": "Drug", 
                "other_name": "Nocturnal nasal room air during stay at 2048 m"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "airway disease", 
            "bronchitis", 
            "emphysema", 
            "lung"
        ], 
        "lastchanged_date": "May 27, 2014", 
        "location": {
            "contact": {
                "email": "konrad.bloch@usz.ch", 
                "last_name": "Konrad E Bloch, MD", 
                "phone": "+41 33 255 3828"
            }, 
            "contact_backup": {
                "email": "tsogyal.latshang@usz.ch", 
                "last_name": "Tsogyal D Latshang, MD", 
                "phone": "+41 33 255 3828"
            }, 
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "zip": "CH-8091"
                }, 
                "name": "University Hospital Zurich, Pulmonary Division"
            }, 
            "investigator": {
                "last_name": "Konrad E Bloch, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Patients With Chronic Obstructive Pulmonary Disease Staying at Altitude - Effect of Nocturnal Oxygen Therapy on Breathing and Sleep in", 
        "overall_contact": {
            "email": "konrad.bloch@usz.ch", 
            "last_name": "Konrad E Bloch, MD", 
            "phone": "+41 44 255 3828"
        }, 
        "overall_contact_backup": {
            "email": "tsogyal.latshang@usz.ch", 
            "last_name": "Tsogyal D Latshang, MD", 
            "phone": "+41 44 255 3828"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Z\u00fcrich", 
            "last_name": "Konrad E Bloch, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethikkommission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Difference in mean nocturnal oxygen saturation between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Mean nocturnal oxygen saturation measured by pulse oximetry", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the first night at 2048 m)"
            }, 
            {
                "description": "Difference in apnea/hypopnea index between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Apnea/hypopnea index measured by polysomnography", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the first night at 2048 m)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02150590"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Difference in mean nocturnal oxygen saturation between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Mean nocturnal oxygen saturation measured by pulse oximetry", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the second night at 2048 m)"
            }, 
            {
                "description": "Difference in apnea/hypopnea index between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Apnea/hypopnea index measured by polygraphy", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the second night at 2048 m)"
            }, 
            {
                "description": "Difference in subjective sleep quality visual analog scale scores between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Subjective sleep quality visual analog scale score", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the first night at 2048 m)"
            }, 
            {
                "description": "Difference in subjective sleep quality between visual analog scale measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Psychomotor vigilance test reaction time", 
                "safety_issue": "No", 
                "time_frame": "Approximately at 10 a.m. on the second day at 2048 m"
            }, 
            {
                "description": "Number of participants in whom arterial oxygen saturation measured by pulse oximetry is less than 75% for more than 30 min during the oxygen and sham oxygen treatment periods at 2028 m.", 
                "measure": "Severe hypoxemia", 
                "safety_issue": "Yes", 
                "time_frame": "Approximately 72 hours (day 1 to 3 at 2048 m)"
            }, 
            {
                "description": "Difference in subjective sleep quality visual analog scale scores between measurements at 2048 m (altitude) and 490 m (baseline); and between the oxygen and sham oxygen treatment periods at 2048 m.", 
                "measure": "Subjective sleep quality visual analog scale score", 
                "safety_issue": "No", 
                "time_frame": "Approximately 8 hours (during the second night at 2048 m)"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}